Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mobile Applications | 2 | 2026 | 140 | 1.630 |
Why?
|
| Epidemics | 2 | 2026 | 27 | 1.050 |
Why?
|
| Communicable Disease Control | 1 | 2026 | 40 | 0.950 |
Why?
|
| Travel | 1 | 2025 | 42 | 0.910 |
Why?
|
| Population Surveillance | 1 | 2025 | 209 | 0.850 |
Why?
|
| Hemorrhagic Fever, Ebola | 4 | 2020 | 29 | 0.840 |
Why?
|
| Lassa Fever | 4 | 2021 | 5 | 0.630 |
Why?
|
| Disease Outbreaks | 4 | 2026 | 111 | 0.490 |
Why?
|
| Machine Learning | 1 | 2016 | 192 | 0.410 |
Why?
|
| Lassa virus | 3 | 2021 | 5 | 0.380 |
Why?
|
| Software | 1 | 2016 | 392 | 0.380 |
Why?
|
| Ebolavirus | 3 | 2020 | 39 | 0.370 |
Why?
|
| Universities | 2 | 2026 | 167 | 0.270 |
Why?
|
| Travel-Related Illness | 1 | 2025 | 5 | 0.240 |
Why?
|
| China | 1 | 2026 | 175 | 0.230 |
Why?
|
| Students | 1 | 2026 | 226 | 0.210 |
Why?
|
| Plasmodium | 1 | 2024 | 33 | 0.200 |
Why?
|
| Borrelia | 1 | 2024 | 31 | 0.200 |
Why?
|
| Host-Pathogen Interactions | 1 | 2026 | 285 | 0.200 |
Why?
|
| Malaria | 1 | 2024 | 155 | 0.180 |
Why?
|
| Sierra Leone | 3 | 2016 | 6 | 0.180 |
Why?
|
| Disaster Planning | 1 | 2021 | 55 | 0.170 |
Why?
|
| Models, Statistical | 2 | 2016 | 308 | 0.170 |
Why?
|
| Humans | 14 | 2026 | 64729 | 0.160 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 70 | 0.140 |
Why?
|
| Female | 6 | 2026 | 33739 | 0.130 |
Why?
|
| Male | 5 | 2026 | 30790 | 0.130 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 2753 | 0.130 |
Why?
|
| Young Adult | 2 | 2025 | 4771 | 0.130 |
Why?
|
| United States | 3 | 2025 | 8041 | 0.130 |
Why?
|
| Adolescent | 2 | 2025 | 6291 | 0.130 |
Why?
|
| Nigeria | 3 | 2021 | 11 | 0.120 |
Why?
|
| User-Computer Interface | 1 | 2016 | 125 | 0.110 |
Why?
|
| Epidemiological Monitoring | 1 | 2014 | 32 | 0.110 |
Why?
|
| Computational Biology | 2 | 2007 | 363 | 0.110 |
Why?
|
| Adult | 4 | 2025 | 17230 | 0.100 |
Why?
|
| Contact Tracing | 2 | 2022 | 17 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 1159 | 0.080 |
Why?
|
| Fever | 2 | 2024 | 66 | 0.080 |
Why?
|
| Middle Aged | 2 | 2025 | 18106 | 0.080 |
Why?
|
| Protein Structure, Secondary | 2 | 2007 | 260 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2016 | 2086 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2018 | 5758 | 0.070 |
Why?
|
| Norovirus | 1 | 2026 | 7 | 0.060 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2026 | 13 | 0.060 |
Why?
|
| Geographic Information Systems | 1 | 2026 | 24 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2023 | 3299 | 0.060 |
Why?
|
| Peptide Library | 1 | 2005 | 33 | 0.060 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2026 | 86 | 0.060 |
Why?
|
| Senegal | 1 | 2024 | 17 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2023 | 512 | 0.040 |
Why?
|
| Africa, Western | 1 | 2021 | 5 | 0.040 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2021 | 8 | 0.040 |
Why?
|
| Peptides | 1 | 2005 | 588 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2021 | 73 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2021 | 198 | 0.040 |
Why?
|
| Public Health | 1 | 2022 | 186 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2019 | 27 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 98 | 0.040 |
Why?
|
| Cognition | 1 | 2023 | 501 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 49 | 0.040 |
Why?
|
| Gestational Age | 1 | 2019 | 195 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 324 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 197 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 1432 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 233 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 2680 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 669 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2019 | 6803 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 929 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1268 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1555 | 0.030 |
Why?
|
| Diarrhea | 1 | 2014 | 73 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2014 | 103 | 0.030 |
Why?
|
| Viral Load | 1 | 2014 | 228 | 0.030 |
Why?
|
| Vomiting | 1 | 2014 | 138 | 0.030 |
Why?
|
| Mortality | 1 | 2014 | 160 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2014 | 142 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 543 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 413 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2014 | 391 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 2363 | 0.020 |
Why?
|
| Base Sequence | 1 | 2014 | 1326 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 2603 | 0.020 |
Why?
|
| Genomics | 1 | 2014 | 384 | 0.020 |
Why?
|
| Carbon | 1 | 2007 | 52 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 2658 | 0.010 |
Why?
|
| Protein Folding | 1 | 2007 | 269 | 0.010 |
Why?
|
| Entropy | 1 | 2005 | 24 | 0.010 |
Why?
|
| Glycine | 1 | 2005 | 49 | 0.010 |
Why?
|
| Databases, Protein | 1 | 2005 | 45 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2005 | 419 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2005 | 790 | 0.010 |
Why?
|
| Proteins | 1 | 2007 | 763 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 21292 | 0.010 |
Why?
|